Roberto Manfredi Selected Research

Highly Active Antiretroviral Therapy (HAART)

10/2006	Need to evaluate the cost effectiveness of early diagnosis and treatment of osteopenia and osteoporosis in the setting of HIV and highly active antiretroviral therapy.
05/2006	Improvement of dyslipidemia during different HAART regimens: tenofovir- versus stavudine-containing antiretroviral combinations.
01/2006	Bladder carcinoma and HIV infection during the highly active antiretroviral therapy era: A rare, but intriguing association. Two case reports and literature review.
05/2004	[Lipodystrophy and lipid metabolism alterations in HIV-infected patients receiving highly active antiretroviral therapy (HAART)]
10/2003	AIDS-associated Cryptococcus infection before and after the highly active antiretroviral therapy era: emerging management problems.
08/2003	Hyperlipidaemia in patients with HIV-1 infection receiving highly active antiretroviral therapy: epidemiology, pathogenesis, clinical course and management.
05/2003	Systemic and discoid lupus erythematosus in HIV-infected patients treated with highly active antiretroviral therapy.
04/2003	[Osteonecrosis in HIV-infected patients and its correlation with highly active antiretroviral therapy (HAART)]
01/2003	Role of Mycobacterium xenopi disease in patients with HIV infection at the time of highly active antiretroviral therapy (HAART). Comparison with the pre-Haart period.
12/2002	Dual Candida albicans and Cryptococcus neoformans fungaemia in an AIDS presenter: a unique disease association in the highly active antiretroviral therapy (HAART) era.
11/2002	Three to seven concurrent AIDS-defining disorders at first hospitalization of AIDS presenters as an unexpected emerging feature during the era of highly active antiretroviral therapy.
11/2002	Subclinical hypothyroidism in HIV-infected patients receiving highly active antiretroviral therapy.
06/2002	[Effects induced by the introduction of highly active antiretroviral therapy (HAART) on disseminated bacterial infection during HIV disease]
02/2002	Enteric and disseminated Campylobacter species infection during HIV disease: a persisting but significantly modified association in the HAART era.

Articles by Research Topic

Disease

5	Infection 07/2008 - 02/2002
5	Acquired Immunodeficiency Syndrome (AIDS) 04/2006 - 11/2002
4	HIV Infections (HIV Infection) 06/2008 - 01/2003
2	Agranulocytosis (Granulocytopenia) 10/2008 - 12/2007
2	Hypersensitivity (Allergy) 07/2007 - 11/2006
2	Meningitis 04/2006 - 01/2004
2	Bacterial Infections (Bacterial Infection) 01/2004 - 06/2002
1	Myasthenia Gravis 09/2008
1	Erythema Nodosum 09/2008
1	Visceral Leishmaniasis (Kala Azar) 06/2008
1	Breast Neoplasms (Breast Cancer) 01/2008
1	Fever of Unknown Origin 12/2007
1	Neutropenia 09/2007
1	Abscess 05/2007
1	Listeria Meningitis 05/2007
1	Exanthema (Rash) 11/2006
1	Metabolic Bone Diseases (Osteopenia) 10/2006
1	Osteoporosis 10/2006
1	Hepatitis C 08/2006
1	Dyslipidemias (Dyslipidemia) 05/2006
1	Meningoencephalitis 04/2006
1	Carcinoma (Carcinomatosis) 01/2006
1	Hepatitis 01/2006
1	Panophthalmitis 01/2006
1	Pulmonary Tuberculosis 01/2006
1	Neoplasms (Cancer) 01/2006
1	Central Nervous System Infections (Central Nervous System Infection) 06/2005
1	Arthritis (Polyarthritis) 01/2005
1	Hypertriglyceridemia 07/2004
1	Lipodystrophy 05/2004
1	Rare Diseases (Rare Disease) 01/2004
1	Lymphoma (Lymphomas) 09/2003
1	Endocarditis 07/2003
1	Discoid Lupus Erythematosus 05/2003
1	Osteonecrosis (Kienbock's Disease) 04/2003
1	Hypothyroidism 11/2002

Drug/Important Bio-Agent (IBA)

4	linezolid (Zyvox)FDA Link 05/2007 - 01/2005
2	liposomal amphotericin B FDA Link 06/2008 - 01/2006
2	InterferonsIBA 09/2007 - 08/2006
2	lopinavir (Kaletra)FDA Link 07/2007 - 11/2006
2	Ribavirin (Virazole)FDA LinkGeneric 08/2006 - 01/2006
1	abacavir (Ziagen)FDA Link 10/2008
1	Carbon MonoxideIBA 07/2008
1	Paromomycin (Paromomycin Sulfate)FDA LinkGeneric 06/2008
1	Pentamidine (NebuPent)FDA LinkGeneric 06/2008
1	AnthracyclinesIBA 01/2008
1	Razoxane (Dexrazoxane)FDA LinkGeneric 01/2008
1	Clozapine (Clozaril)FDA LinkGeneric 12/2007
1	Filgrastim (Neupogen)FDA Link 09/2007
1	Ritonavir (Norvir)FDA Link 07/2007
1	Stavudine (Zerit)FDA Link 05/2006
1	tenofovirIBA 05/2006
1	Amphotericin B (Amphotericin)FDA LinkGeneric 04/2006
1	voriconazole (Vfend)FDA Link 01/2006
1	Fluconazole (Zonal)FDA LinkGeneric 01/2006
1	Interleukin-7 (Interleukin 7)IBA 01/2006
1	Interferon-alpha (Interferon Alfa)FDA Link 01/2006
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2006
1	caspofungin (Cancidas)FDA Link 01/2006
1	Rifampin (Rifampicin)FDA LinkGeneric 01/2005
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)FDA Link 07/2004
1	EstersIBA 07/2004
1	Propofol (Diprivan)FDA LinkGeneric 01/2004
1	Octreotide (Sandostatin)FDA LinkGeneric 01/2004
1	Immunoglobulin A (IgA)IBA 01/2004
1	rituximab (Mabthera)FDA Link 09/2003
1	TeicoplaninIBA 07/2003
1	Gentamicins (Gentamicin)FDA LinkGeneric 07/2003
1	Ampicillin (Omnipen)FDA LinkGeneric 07/2003

Therapy/Procedure

14	Highly Active Antiretroviral Therapy (HAART) 10/2006 - 02/2002
1	Thymectomy 09/2008
1	Aftercare (After-Treatment) 04/2006